Application no. and date | 01980710.6 (espacenet) (Federated) (European Patent Register), 20011106 | Patent/reg. no. and date | DK/EP 1365808, 20110119 | Publication date | 20031203 | Priority no. and date | US 246233 P, 20001106, US 248095 P, 20001113, US 345982 P, 20011019 | EP pub. no. and date |
EP 1365808 20031203 | Effective date | | Applicant/owner | PHARMA MAR, S.A., Calle de la Calera 3, Poligono Industrial de Tres Cantos
28760 Tres Cantos, Madrid, ES | Applicant ref. no. | 10321-4 | Inventor | TAKAHASHI, Naoto, Memorial Sloan Kettering 1275 York Avenue
New York, NY 10021, US, D'INCALCI, Maurizio, Institute de Recercher Farmacologiche Mario Negri
Milan, IT, GIAVAZZI, Rafaella, Inst. de la Recerche Farmacologiche Mario Negri
I- Milan, IT, GESCHER, Andreas, 7 Swithland Court
Brand Hill, Woodhouse Eaves LE12 8SS, GB, WEITMAN, Steve, c/o Institute for Drug Development, Cancer Therapy & Res. Center (CTRC), 14960 Omicron
San Antonio, TX 78245-3217, US, FAICLOTH, Glynn, Thomas, c/o PharmaMar USA, Inc., 320 Putnam Avenue
Cambridge, MA 02139-4616, US | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | Opponent | | IPC Class | A61K 31/495 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) | Title | Sammensætninger til antitumorbehandling indeholdende ecteinascidin 743 | Int. application no. | GB2001004902 | Int. publication no. | WO2002036135 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|